Parmax Pharma - Quaterly Results

14 Feb 2025 Evaluate
The Total revenue for the quarter ended December 2024 of  Rs. 62.84 millions grew by 373.55% from Rs. 13.27 millions.The Net Loss for the quarter ended December 2024 is Rs. -3.94 millions as compared to Net Loss of Rs. -17.53 millions of corresponding quarter ended December 2023 Operating profit Margin for the quarter ended December 2024 improved to 1.21% as compared to -11.43% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 62.84 13.27 373.55 233.77 67.95 244.03 110.53 154.24 -28.34
Other Income 0.13 0.11 18.18 1.38 0.34 305.88 0.48 0.40 20.00
PBIDT 1.21 -11.43 -110.59 9.58 -25.36 -137.78 -33.23 22.93 -244.92
Interest 1.06 1.56 -32.05 3.48 4.59 -24.18 6.22 3.69 68.56
PBDT 0.15 -12.99 -101.15 6.10 -29.95 -120.37 -39.45 19.24 -305.04
Depreciation 4.09 4.54 -9.91 12.08 13.05 -7.43 17.12 18.79 -8.89
PBT -3.94 -17.53 -77.52 -5.98 -43.00 -86.09 -56.57 0.45 -12671.11
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.95 1.50 -36.67
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.95 -0.35 -371.43
PAT -3.94 -17.53 -77.52 -5.98 -43.00 -86.09 -57.52 -1.05 5378.10
Equity 37.41 37.41 0.00 37.41 37.41 0.00 37.41 37.41 0.00
PBIDTM(%) 1.93 -86.13 -102.24 4.10 -37.32 -110.98 -30.06 14.87 -302.23

Parmax Pharma Share Price

35.04 0.52 (1.51%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×